Dr. Yongyuth Yuthavong studied in the UK with a Thai Government scholarship. He received a first-class honors bachelor degree in chemistry from London University and a doctoral degree in organic chemistry from Oxford University. He worked at Mahidol University, and was given the “Outstanding Scientist of Thailand” Award in 1984 for his research on malaria biochemistry. In 2004, he received the Nikkei Asia Prize for Science, Technology and Innovation from the Nihon Keizai Shimbun, Japan, for his work on antimalarial drug targets and antimalarial development. He was the first President of Thailand National Science and Technology Development Agency, a former Director of the National Centre for Genetic Engineering and Biotechnology, a former Minister of Science and Technology and a former Deputy Prime Minister of Thailand.

Dr. Wiwat Rojanapithayakorn is the Representative of the World Health Organization in Mongolia. He has been working with WHO since 2002 in the capacities of Medical Officer of WHO Mongolia (2002-2004), HIV/AIDS Team Leader of WHO China (2005-2008) and the current position since 2009. Before joining WHO he was the Team leader of UNAIDS Southeast Asia and Pacific Inter-Country Team based in Bangkok (for 2.5 years). He had worked in Ministry of Public Health of Thailand for 23 years in different capacities such as director of 2 community hospital, chief of epidemiology section of venereal disease division, the first director of national AIDS programme, the director of a regional office of communicable disease control, the first director of the dengue control office, a chief medical officer and a senior advisor in disease control. He has authored or co-authored more than 100 publications in English and Thai, and was editor or chief editor of over 10 public health journals.

In 1989, Dr Wiwat created the 100% Condom Use Programme (CUP) which has been subsequently implemented throughout Thailand and replicated in many countries in Asia. The approach has been widely recognized as an effective intervention for HIV/STI prevention. In 2010, he received a Prince Mahidol Award in Public Health from his efforts in the development and scaling-up the 100% CUP which prevented millions of HIV infection in Thailand and some Asian countries.

Dr. Jackson is Professor of Medicine (Neurology) and of Medical Microbiology and also Head of the Section of Neurology at University of Manitoba in Winnipeg, Manitoba, Canada since 2007. He graduated from Queen's University with B.A. (magna cum laude) and M.D. degrees. He completed an internship in internal medicine at University of Southern California, residencies in internal medicine at Queen's University and in neurology at Western University (formerly University of Western Ontario), and a fellowship in neurovirology at The Johns Hopkins University with the late Dr. Richard Johnson and Dr. Diane Griffin. Dr. Jackson held a faculty position at Queen's University from 1987 - 2007. He was the first President of Rabies in the Americas, Inc. and he has served on the Board of Directors of the International Society for Neurovirology since 2000. He is a fellow of the Royal College of Physicians and Surgeons of Canada, the American Neurological Association, and the American Academy of Neurology. Dr. Jackson has many research publications on aspects of the pathogenesis of rabies virus infection and he has been the principal investigator on research grants to study experimental aspects of rabies. He has also edited/co-edited four books on rabies and one on viral infections of the nervous system.

Professor Istvan Toth, Ph.D., D.Sc. is a chemical engineer and an internationally recognized expert in drug delivery. His major research interests are immunoadjuvants, carbohydrates, lipids, peptides, nucleosides and nucleotides. New developments in drug/vaccine delivery are clearly likely to have enormous economic impacts upon the pharmaceutical and biotechnology industries. He is a Fellow of the Royal Australian Chemical Institute (FRACI) the Queensland Academy of Science and Art (FQA) and the Hungarian Academy of Sciences

BIT's 7th Annual World Congress of Infectious Diseases (WCID-2018)
About WCID-2018

The 7th Annual World Congress of Infectious Diseases (WCID-2018) will be held during July 12-14, 2018, at Bangkok, Thailand with the theme “World Dream of Eradicating Infection”.
Including 7 research fields in infection diseases, 50 parallel sessions, with attendees coming from all over the world, WCID-2018 will bring together scientists from the industry, academia, as well as leaders from healthcare providers, policy makers and investors to provide unique insights for infectious disease research. This event will also have a specific focus on co-operations between countries of the world through exhibitions and oral presentations by specialists in the field.
It will be a wonderful platform for communication and cooperation. We ensure you a worthwhile trip!

Keynote Speakers of WCID-2018
Dr. Yongyuth Yuthavong, Thailand National Centre for Genetic Engineering and Biotechnology (BIOTEC), Thailand
Dr. Wiwat Rojanapithayakorn, Director of the Center for Health Policy and Management, Faculty of Medicine Ramathibodi Hospital; Former first Director, Prevention and Control of AIDS Center, Ministry of Public Health, Thailand
Dr. Istvan Toth, Professor, the University of Queensland, Australia
Dr. Alan C. Jackson, Professor and Head, Section of Neurology, Department of Internal Medicine, Professor, Department of Medical Microbiology, University of Manitoba, Canada
Renowned Speakers
Dr. Ali Azizi,
Senior Scientist, Sanofi Pasteur, Canada
Dr. Nicholas R. J. Gascoigne,
President, Singaporean Society for Immunology, Singapore
说明: D:\WU\wcid2018\照片\Amal Amer.jpg Dr. Amal Amer,
Professor, Ohio State University, USA
说明: D:\WU\wcid2018\照片\Dmitry Lozovoy.jpg Dr. Dmitry A. Lozovoy,
Director, FGBI ARRIAH, Russia
说明: D:\WU\wcid2018\照片\Filippo Bosco.jpg Dr. Filippo Bosco,
CEO& Founder, BluSense Diagnostics ApS, Denmark
Dr. Galina A. Eroshenko,
Chief Researcher, Russian Research Anti-Plague Institute “Microbe”, Russia
说明: D:\WU\wcid2018\照片\Juan J.jpg Dr. Juan J. Picazo,
Emeritus Chairman, Department of Medicine, University Complutense of Madrid, Spain
Dr. Justin Jang Hann,
Associate Professor, National University of Singapore, Singapore
Dr. Neil Norcross,
Medicinal Chemistry Project Leader, Drug Discovery Unit, University of Dundee, UK
Dr. Michael R Barer,
Professor, University Rd, UK
Dr. Mohammed Alsharifi,
Chief Scientific Officer for Gamma Vaccines Pty Ltd, Head, Vaccine Research Group, Department of Molecular and Biomedical Science, School of Biological Sciences, University of Adelaide, Australia
Dr. Kovit Pattanapanyasat,
Professor, Research Head, Center of Research Excellence for Exosome and Microparticle in Diseases, Mahidol University, Thailand
Dr. Andrew A. Potter,
Director, University of Saskatchewan, Canada
Dr. Alan C. Jackson,
Professor and Head, Section of Neurology, Department of Internal Medicine, Department of Medical Microbiology, University of Manitoba, Canada
Dr. Visula Abeysuriya,
Research fellow, Nawaloka Hospital Research and Education Foundation, Nawaloka Hospitals PLC, Colombo, Sri Lanka
Dr. Yongliang Zhang,
Assistant Professor, University of Singapore, Singapore
Dr. Nelun Perera,
MBBS, DipMicro (Sri Lanka), FRCpath (UK), MDMicro (Sri Lanka), PGCertMedEd (Cambridge), Consultant Microbiologist & Hon Associate Professor, University Hospitals of Leicester & University of Leicester, UK
Dr. Erkin Musabaev,
Director, The Institute of Virology at the Ministry of Health, Uzbekistan
Dr. Tian Wang,
Professor, University of Texas Medical Branch, USA
Dr. Istvan Toth,
Professor, The University of Queensland, Australia
Dr. Dirar Abdallah,
Consultant Internal Medicine, Head of Adult Critical Care Services, Prime Hospital, Dubai-UAE
Dr. Claire Chewapreecha,
Lecturer, King Mongkut University of Technology Thonburi, Thailand
Dr. Henry Stephens,
Consultant Clinical Scientist, UCL Centre for Nephrology and Anthony Nolan Laboratories, Royal Free Hospital London, UK
Mr. Ib Ostergaard Hansen,
Chairman, Humana People to People, Zimbabwe
Exhibition and Posters

WCID-2018 provides an ideal platform to showcase your new technologies and products here. It is developed to maximize exposure of exhibitors, with coffee breaks and poster sessions for delegates taking place in the exhibition area.

Why Reserve a Booth at WCID-2018

• Exposure Your New Products, Technology, Innovations and Latest Development to Visitors
• Explore Business Opportunities All Over the World
• Interaction with Visitors Face-to-Face, Exchanging Conversation and Sharing Information
• Spotlight Your Technology and Its Commercial Application Promote Business
• Take Advantage of the Targeted Audience at the Conference and Network in the Hall
• Highlight your Impact and Influence
• Increased Visibility and Name Recognition
• Access to Competitive Intelligence


Social and Cultural Activities

Activity 1: Welcome Banquet and Art Performance
Activity 2: Industrial Sponsored Cocktail Party
Activity 3: Field Trip to Industry Park/Universities
Activity 4: Thailand Impression Tech-Tour

Group Photo
News Release

• On-Site Photo Download
• Speaking proposals are now being accepted, submit the abstract right now!
Online Registration is Open.
• Website of WCID-2018 Released!
• Welcome your participation as Session Chair/Session Speaker.
• Seek for Co-Organizer.
• Call for SAB Member.

Hosting Organization
Official Travel Agency
Media Partners

BIT's Upcoming Events
Contact Us

Add: East Area, F11, Building 1, Dalian Ascendas IT Park, 1 Hui Xian Yuan, Dalian Hi-tech Industrial Zone, LN 116025, China
Tel: 0086-411-84799609, Fax: 0086-411-84796897
Copyright © 2017-2018 BIT Group Global Ltd.